ATE493430T1 - Pantropisches hundecoronavirus - Google Patents
Pantropisches hundecoronavirusInfo
- Publication number
- ATE493430T1 ATE493430T1 AT05023371T AT05023371T ATE493430T1 AT E493430 T1 ATE493430 T1 AT E493430T1 AT 05023371 T AT05023371 T AT 05023371T AT 05023371 T AT05023371 T AT 05023371T AT E493430 T1 ATE493430 T1 AT E493430T1
- Authority
- AT
- Austria
- Prior art keywords
- canine
- pantropic
- ecoronavirus
- prophylaxis
- dogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/102—Coronaviridae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05023371A EP1780216B1 (de) | 2005-10-26 | 2005-10-26 | Pantropisches Hundecoronavirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE493430T1 true ATE493430T1 (de) | 2011-01-15 |
Family
ID=36046489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05023371T ATE493430T1 (de) | 2005-10-26 | 2005-10-26 | Pantropisches hundecoronavirus |
Country Status (5)
| Country | Link |
|---|---|
| EP (2) | EP2283859A3 (de) |
| AT (1) | ATE493430T1 (de) |
| DE (1) | DE602005025649D1 (de) |
| ES (1) | ES2355702T3 (de) |
| PT (1) | PT1780216E (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20111182A1 (it) * | 2011-06-28 | 2012-12-29 | Canio Buonavoglia | Vaccino per coronavirus canino |
| CN103911462B (zh) * | 2014-04-03 | 2015-06-10 | 河北国际旅行卫生保健中心 | 黄热、乙型脑炎、基孔肯雅、西尼罗的鉴别检测方法及引物和探针 |
| CN107831317A (zh) * | 2017-11-01 | 2018-03-23 | 杭州微瑞科技有限公司 | 犬冠状病毒抗体快速定量检测卡及使用方法 |
| CN116375854A (zh) * | 2023-04-18 | 2023-07-04 | 领地动物诊疗科技(厦门)有限公司 | 抗犬冠状病毒n蛋白抗体对及其制备方法、核酸分子、细胞株和应用 |
| CN119331833B (zh) * | 2024-09-28 | 2025-10-03 | 华中农业大学 | 一株犬冠状病毒弱毒株CCoV AS22及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4567042A (en) * | 1983-06-15 | 1986-01-28 | American Home Products Corporation | Inactivated canine coronavirus vaccine |
| US4904468A (en) * | 1987-06-08 | 1990-02-27 | Norden Laboratories, Inc. | Canine coronavirus vaccine |
| EP0510773B1 (de) * | 1991-04-25 | 2003-12-17 | Akzo Nobel N.V. | Subeinheits-Impfstoff gegen Hundecoronavirus |
| GB0217434D0 (en) * | 2002-07-27 | 2002-09-04 | Royal Vetinary College | Biological material |
-
2005
- 2005-10-26 AT AT05023371T patent/ATE493430T1/de not_active IP Right Cessation
- 2005-10-26 PT PT05023371T patent/PT1780216E/pt unknown
- 2005-10-26 EP EP20100176280 patent/EP2283859A3/de not_active Withdrawn
- 2005-10-26 EP EP05023371A patent/EP1780216B1/de not_active Expired - Lifetime
- 2005-10-26 ES ES05023371T patent/ES2355702T3/es not_active Expired - Lifetime
- 2005-10-26 DE DE602005025649T patent/DE602005025649D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1780216A1 (de) | 2007-05-02 |
| EP2283859A2 (de) | 2011-02-16 |
| ES2355702T3 (es) | 2011-03-30 |
| DE602005025649D1 (de) | 2011-02-10 |
| PT1780216E (pt) | 2011-02-03 |
| EP1780216B1 (de) | 2010-12-29 |
| EP2283859A3 (de) | 2011-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL301089I2 (nl) | imlifidase | |
| HUS1800019I1 (hu) | Acilezett GLP-1 vegyületek | |
| CR20110206A (es) | Método de uso de una sepa de bacillus subtilis para mejorar la salud de animales | |
| EP2087772A4 (de) | Lichtquelle mit lichtemittierenden clustern | |
| NO20063624L (no) | FC region varianter | |
| AR061446A1 (es) | Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico | |
| PT2987796T (pt) | Boronoftalidas substituídas por halogéneo para o tratamento de infecções | |
| BRPI0717753A2 (pt) | Método de tratamento ou redução do risco de uma doença causada por protozoários, e, composição. | |
| NI200500139S (es) | Mordedor para perro caso 29/223,860 | |
| EA201100297A1 (ru) | Биотесты на белок polyq | |
| CR10165A (es) | "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión" | |
| NL2000373A1 (nl) | Antibacteriele middelen. | |
| CR11473A (es) | Uso de 3,11 b-cis-dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria | |
| PT2056804E (pt) | Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares | |
| DK1765318T3 (da) | Middelkæde fedtsyrer anvendelige som antimikrobielle midler | |
| AR057643A1 (es) | Lacosamida para terapia adjunta | |
| DE602006001073D1 (de) | Viehmarke | |
| ATE493430T1 (de) | Pantropisches hundecoronavirus | |
| BR0312211A (pt) | difluortioacetamidas de oxazolidinonas como agentes antibacterianos | |
| AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
| GT200500308A (es) | Nonadepsipeptidos acilados ii | |
| UY30769A1 (es) | Uso de epotilonas en el tratamiento de la osteoporosis y enfermedades relacionadas | |
| EP1793984A4 (de) | Entsafter mit antriebs- und rückführnocken für entsafterschalenbewegung | |
| AR055072A1 (es) | Uso de anticuerpos anti- madcam para el tratamiento de enfermedad celiaca y esprue tropical | |
| ITTV20050186A1 (it) | Lettino per l'abbronzatura del corpo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |